KROS · Keros Therapeutics, Inc. · Exempt Offerings
Market Cap
$224.44M
Shares
19.83M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
Key facts
CIK
1664710
CUSIP
492327101
13F (30d)
94 filings
94 filers
Visit website
Investor relations